Morningstar Investor users sign in here.

Company Profile

  • Business description

    Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

  • Contact

    1000 Mylan Boulevard
    Canonsburg PA 15317
    USA

    T: +1 724 514-1800

    E: InvestorRelations@Viatris.com

    https://www.viatris.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    38,000

Stocks News & Analysis

stocks

This undervalued ASX share just had a moat downgrade

Morningstar’s Brian Han downgrades the company’s moat rating and cuts fair value however shares remain at an attractive discount. 
stocks

This ASX share has been awarded a moat by our analysts

Along with the narrow moat rating we raised our fair value by 12%.
video

Now the dust has settled, a mini earnings wrap

Three of our equity analysts reflect on the best results, worst disappointments and biggest market overreactions from their sectors.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,361.20 20.10 0.24%
CAC 40 7,499.59 50.15 0.67%
DAX 40 18,760.63 127.52 0.68%
Dow JONES (US) 41,832.23 210.15 0.50%
FTSE 100 8,319.28 40.84 0.49%
HKSE 17,660.02 237.90 1.37%
NASDAQ 17,730.88 138.76 0.79%
Nikkei 225 36,203.22 378.54 -1.03%
NZX 50 Index 12,671.95 32.44 -0.26%
S&P 500 5,665.67 32.58 0.58%
S&P/ASX 200 8,140.90 19.30 0.24%
SSE Composite Index 2,704.09 13.03 -0.48%

Market Movers

Name
Last price
Change
% Change
Telstra Group Ltd TLS 4.02 0.01 0.25%
Resolute Mining Ltd RSG 0.72 0.01 -0.69%
Imugene Ltd IMU 0.05 0.00 -4.00%
Pilbara Minerals Ltd PLS 2.85 0.03 -1.04%
Red 5 Ltd RED 0.33 0.01 1.54%
Sayona Mining Ltd SYA 0.02 0.00 0.00%
Westgold Resources Ltd WGX 2.67 0.09 -3.26%
South32 Ltd S32 3.23 0.06 1.89%
Appen Ltd APX 1.61 0.11 6.98%
Core Lithium Ltd CXO 0.10 0.00 -3.06%